Skip to main content
FinSpry Logo
FinSpry
RNXT logo
RNXT
(NASDAQ)
RenovoRx, Inc.
$0.98-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

RenovoRx (RNXT) Stock Price & Financial Analysis

RenovoRx Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.95 - $1.03
52-Week High$1.45
52-Week Low$0.70
Open$0.96
Volume130.09K
Average Volume (3M)130.09K
Market Cap35.91M
Shares Outstanding36.65M
Price to Sales (P/S)38.30
Price to Book (P/B)4.40
EV/EBITDA-2.86
Revenue (TTM)928.00K
Net Income (TTM)-11.11M
Free Cash Flow (TTM)-10.40M
EPS (TTM)$-0.30
Profit Margin-1196.66%
Operating Margin-1252.16%
Return on Equity (ROE)-137.47%
Debt to Equity0.03
50-Day MA$0.95
200-Day MA$1.07
52-Week Change1.04%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About RenovoRx

What is the current stock price for RNXT?

As of the latest trading session, RNXT stock trades at $0.98. The 52-week range is $0.70–$1.45, with a day range of $0.95–$1.03.

What is the P/E ratio for RNXT?

The P/E ratio (Price-to-Earnings) for RNXT is shown in the Key Statistics section. This valuation metric helps compare RenovoRx, Inc. to industry peers.

Does RNXT pay dividends?

RenovoRx does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RNXT?

Based on 1 analyst, the consensus for RNXT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RNXT?

RenovoRx's market capitalization is $35.9M, classifying it as a micro-cap company. RenovoRx operates in the Healthcare sector within the Biotechnology industry.